Cytori Therapeutics Announces Company Presentation the 2012 Stem Cell Meeting on the Mesa’s Investor and Partnering Forum on

  Cytori Therapeutics Announces Company Presentation the 2012 Stem Cell
  Meeting on the Mesa’s Investor and Partnering Forum on October 30

Business Wire

SAN DIEGO -- October 26, 2012

Cytori Therapeutics, Inc. (NASDAQ: CYTX) will give a company presentation at
the 2012 Stem Cell Meeting on the Mesa’s Investor and Partnering Forum on
Tuesday, October 30.

The following are specific details regarding Cytori’s presentation at the
conference:

Date:      October 30th, 2012
Time:       1:45pm PT
Location:   Sanford Consortium for Regenerative Medicine Building Auditorium,
            2^nd Floor Terrace
            2880 Torrey Pines Scenic Drive, La Jolla, California

The presentation will be recorded and will be available on the Webcasts page
of the Cytori’s investor relations site the week following the conference.

The Investor and Partnering Forum is being organized by the Alliance for
Regenerative Medicine (ARM) and the California Institute for Regenerative
Medicine to profile the industry’s most exciting technologies.

About Cytori

Cytori Therapeutics, Inc. is developing cell therapies based on autologous
adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and
repair soft tissue defects. Our scientific data suggest ADRCs improve blood
flow, moderate the immune response and keep tissue at risk of dying alive. As
a result, we believe these cells can be applied across multiple "ischemic"
conditions. These therapies are made available to the physician and patient at
the point-of-care by Cytori's proprietary technologies and products, including
the Celution® system product family. www.cytori.com

Contact:

Cytori Therapeutics, Inc.
Megan McCormick, +1-858-875-5279
mmccormick@cytori.com